1. Home
  2. PTHL vs DSS Comparison

PTHL vs DSS Comparison

Compare PTHL & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • DSS
  • Stock Information
  • Founded
  • PTHL 1998
  • DSS 1984
  • Country
  • PTHL China
  • DSS United States
  • Employees
  • PTHL N/A
  • DSS N/A
  • Industry
  • PTHL
  • DSS Containers/Packaging
  • Sector
  • PTHL
  • DSS Consumer Discretionary
  • Exchange
  • PTHL Nasdaq
  • DSS Nasdaq
  • Market Cap
  • PTHL 13.5M
  • DSS 11.6M
  • IPO Year
  • PTHL 2024
  • DSS N/A
  • Fundamental
  • Price
  • PTHL $0.91
  • DSS $1.25
  • Analyst Decision
  • PTHL
  • DSS
  • Analyst Count
  • PTHL 0
  • DSS 0
  • Target Price
  • PTHL N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • PTHL 1.8M
  • DSS 788.2K
  • Earning Date
  • PTHL 01-01-0001
  • DSS 11-12-2025
  • Dividend Yield
  • PTHL N/A
  • DSS N/A
  • EPS Growth
  • PTHL N/A
  • DSS N/A
  • EPS
  • PTHL N/A
  • DSS N/A
  • Revenue
  • PTHL $448,196.00
  • DSS $21,252,000.00
  • Revenue This Year
  • PTHL N/A
  • DSS N/A
  • Revenue Next Year
  • PTHL N/A
  • DSS N/A
  • P/E Ratio
  • PTHL N/A
  • DSS N/A
  • Revenue Growth
  • PTHL N/A
  • DSS 10.24
  • 52 Week Low
  • PTHL $0.51
  • DSS $0.72
  • 52 Week High
  • PTHL $32.00
  • DSS $1.90
  • Technical
  • Relative Strength Index (RSI)
  • PTHL 30.66
  • DSS 54.41
  • Support Level
  • PTHL $0.82
  • DSS $1.10
  • Resistance Level
  • PTHL $0.98
  • DSS $1.44
  • Average True Range (ATR)
  • PTHL 0.17
  • DSS 0.22
  • MACD
  • PTHL 0.53
  • DSS -0.00
  • Stochastic Oscillator
  • PTHL 55.65
  • DSS 27.12

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: